Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2005; 130(42): 2384-2388
DOI: 10.1055/s-2005-918580
DOI: 10.1055/s-2005-918580
Aktuelle Diagnostik & Therapie
Radiologie / Onkologie
© Georg Thieme Verlag Stuttgart · New York
Hirnmetastasen: aktueller Stand der Diagnostik und Therapie
Cerebral metastases - diagnostics and treatmentFurther Information
Publication History
eingereicht: 13.5.2005
akzeptiert: 4.8.2005
Publication Date:
19 October 2005 (online)

Glossar
CT: Computertomographie
CUP: Carcinoma of unknown primary
FDG-PET: Fluoreszenzdesoxyglucose-Positronenemissionstomographie
Gy: Gray
KM-CT: Kontrastmittel-Computertomographie
MRT: Magnet-Resonanz-Tomographie
PET: Positronenemissionstomographie
SPECT: Single-Photon Emissionscomputertomographie
Literatur
- 1 Alberini J L, Belhocine T, Hustinx R. et al . Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome). Nucl Med Commun. 2003; 24 1081-1086
- 2 Bouffet E, Doumi N, Thiesse P. et al . Brain metastases in children with solid tumors. Cancer. 1997; 79 403-410
- 3 Coia L R, Aaronson N, Linggood R. et al . A report of the consensus workshop panel on the treatment of brain metastases. Int J Radiat Oncol Biol Phys. 1992; 23 223-227
- 4 Delattre J Y, Krol G, Thaler H T, Posner J B. Distribution of brain metastases. Arch Neurol. 1988; 45 741-744
-
5 Deutsche Gesellschaft für Neurologie .Leitlinie Hirnmetastasen;. www.dgn.org/81.0.html
- 6 Engenhart R, Kimmig B N, Hover K. et al . Long-term follow up for brain metastases treated by percutaneous single high dose radiation. Cancer. 1993; 71 1353-1361
- 7 Epstein B E, Scott C B, Sause W T. et al . Improved survival duration in patients with unsresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54,4 Gy and greater. Cancer. 1993; 71 1362-1367
- 8 Gross M, Klauss H, Engenhart R. Strahlentherapeutisches Management von Hirnmetastasen. Onkologe. 2000; 6 948-958
- 9 Grosu A, Feldmann H J, Stärk S. et al . Stereotaktische Strahlentherapie am adaptierten Linearbeschleuniger bei Patienten mit Hirnmetastasen. Der Nervenarzt. 2001; 72 770-781
- 10 Jereczyk-Fossa B A, Jassem J, Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev. 2004; 30 153-164
- 11 Johnson J D, Young B. Demographics of brain metastasis. Neurosurg Clin N Am. 1996; 7 337
- 12 Knoop M, Sola S, Hebecker R. et al . Seltene pulmonalen Manifestation eines intrakraniellen meningothelialen Meningeoms. Dtsch Med Wochenschr. 2004; 129 1854-1857
- 13 Kondziola D, Patel A, Lundsford L D. et al . Stereotactic radiosurgery plus brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999; 45 427-434
- 14 Korfol A, Thiel E. Chemotherapie zerebraler Metastasen solider Tumoren. Onkologe. 2000; 6 959-965
- 15 Lagerwaard F J, Levendag P C, Nowak P J. et al . Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys. 1999; 43 795-804
- 16 Mehta M P, Rozental J M, Levin A B. et al . Defining the role of stereotactic radiosurgery in the management of brain metastases. Int J Radiat Oncol Biol Phys. 1992; 24 619-625
- 17 Patchell R A, Tibbs P A, Walsh J W. et al . A randomised trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990; 322 494-500
- 18 Pickren J W, Lopez G, Tsukada Y, Lane W W. Brain metastases: An autopsy study. Cancer Treat Sym. 1983; 2 295-313
- 19 Regine W F, Mohiuddin M, Tibbs P A. et al . A randomised prospective trial of the benefit of postoperative radiotherapy in the treatment of single metastases to the brain. Int J Radiat Oncol Biol Phys. 1998; 42 1996
- 20 Schackert G, Steinmetz A, Sobottka S. Neurochirurgische Therapie der Hirnmetastasen. Onkologe. 2000; 6 939-947
- 21 Schmid U D, Honegger H P, Pescia R. Chirurgie der Hirnmetastasen. Schweiz Med Forum. 2002; 50 1187-1194
- 22 Shaw E G, Scott C, Souhami L. et al . Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90 - 05. Int J Radiat Oncol Biol Phys. 2000; 47 291-298
- 23 Varadhacary G R, Abbruzzese J L, Lenzi R. Diagnostic strategies for for unknown primary cancer. Cancer. 2004; 100 1776-1785
- 24 Vecht C J, Haaxma-Reiche H, Noordijk E M. et al . Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?. Ann Neurol. 1993; 33 583-590
- 25 Vecht C J, Hovestadt A, Verbiest H B. et al . Dose-effect relationship of dexametasone on Karnofsky performance in metastatic brain tumors: a randomised study of doses 4, 8, and 16 mg per day. Neurology. 1994; 44 675-680
- 26 Wen P Y, Loeffler J S. Management of brain metastases. Oncology. 1999; 13 941-954
Dr. med. F. Gundling
II. Medizinische Abteilung für Gastroenterologie, Hepatologie und Gastroenterologische Onkologie, Städtisches Krankenhaus München-Bogenhausen
Englschalkinger Straße 77
81925 München
Phone: 089/92702061
Fax: 089/92702486
Email: Gastroenterologie@kh-bogenhausen.de